Skip to main content
Clinical Trials/NCT00618553
NCT00618553Active, not recruitingPhase 2

The Efficacy of Pulmonary Rehabilitation in Improving Surgical Eligibility for Lung Resection

M.D. Anderson Cancer Center1 site in 1 country75 target enrollmentStarted: January 28, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Active, not recruiting
Enrollment
75
Locations
1
Primary Endpoint
Treatment Success (conversion from ineligible to eligible status for lung resection following Pulmonary rehabilitation (PR))

Study Overview

Brief Summary

The goal of this clinical research study is to see if pulmonary rehabilitation can improve patients' lung function, which would increase their chances of becoming eligible for surgery. The health of pulmonary rehabilitation participants after surgery will also be examined.

Detailed Description

Pulmonary rehabilitation is a process that is designed to improve patients' lung function, muscular conditioning, exercise performance, and overall quality of life.

Study activities include exercise training, patient and family education, and psychosocial and behavioral counseling provided by a healthcare team.

Rehabilitation plans will vary patient by patient based on the results of the following tests:

  • Blood (1-3 tablespoons) will be drawn for routine tests.
  • You will have an electrocardiogram (ECG -- a test that measures the electrical activity of the heart).
  • You will have an X-ray of your chest.
  • You will have a Pulmonary Function Test. For this test, you will be asked to breathe in several different ways while you have a mouthpiece in your mouth to test your lung function.

Study Visits:

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with anatomically resectable lung tumors who are deemed surgically inoperable based on preoperative pulmonary function testing FEV1 < 80% pred; DLCO < 80% pred; FEV1ppo < 40% pred; DLCO ppo < 40% pred AND VO2 peak < 60% predicted or < 15 ml/kg/min.
  • Patients deemed surgically inoperable based on poor performance status (ECOG score 2-3)
  • Any non-pulmonary co-morbidity must be stable according to institutional guidelines.

Exclusion Criteria

  • Previously reported severe pulmonary hypertension (pulmonary artery systolic pressure > 60 as determined by echocardiogram), refractory cor pulmonale (as manifested by right ventricular dilatation or dysfunction by echocardiogram)
  • Previously reported exercise-induced syncope, angina, palpitation, arrhythmia, hypotension (drop of 20% of systolic/diastolic from baseline)
  • History of severe congestive heart failure (NYHA class 3 and 4) refractory to medical management, (LVEF < 40% by echocardiogram).
  • Bone metastasis
  • Active psychiatric illness that could interfere with treatment.

Arms & Interventions

Pulmonary Rehabilitation

Experimental

Pulmonary Rehabilitation - Rehabilitation treatment given over about 3-4 weeks. Questionnaire regarding quality-of-life that lasts about 30 minutes.

Intervention: Questionnaire (Other)

Pulmonary Rehabilitation

Experimental

Pulmonary Rehabilitation - Rehabilitation treatment given over about 3-4 weeks. Questionnaire regarding quality-of-life that lasts about 30 minutes.

Intervention: Pulmonary Rehabilitation (Behavioral)

Outcomes

Primary Outcomes

Treatment Success (conversion from ineligible to eligible status for lung resection following Pulmonary rehabilitation (PR))

Time Frame: Baseline and post treatment (following 3-4 weeks of PR)

Secondary Outcomes

  • Examine health of pulmonary rehabilitation participants after surgery.(2 Years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Effect of Pulmonary Rehabilitation on... | Clinical Trial